Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AI and Machine Learning
Biotech
Boehringer continues kidney dealmaking with $120M Variant pact
Boehringer unveiled its second kidney-focused collab in recent weeks, this time penning a deal worth up to $120 million with genomics-focused Variant.
James Waldron
Jan 6, 2026 10:45am
Sanofi's 2nd autoimmune pact with AI biotech could reach $2.5B
Jan 5, 2026 7:30am
Editor's corner: Fierce Medtech's top 10 stories of 2025
Dec 22, 2025 10:30am
Hologic breast cancer study bolsters use of mammogram AI
Dec 22, 2025 10:25am
BD's Bilal Muhsin on what good AI can still do for healthcare
Dec 19, 2025 2:36pm
Verge drops sole clinical candidate in return to AI roots
Dec 18, 2025 10:04pm